Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Q: Luke Miels, who joined GSK in September 2017 after a contract dispute with his former employer AstraZeneca, said picking the most promising projects and developing them quickly now takes precedence over spreading the risk of failure. "In the past, 10 programs were chosen, a budget for eight was allocated. Usually what happened was that time was the trade off that was made," he said in an interview. "Now what we do is we pick five or six programs, and concentrate investment there." GSK, like rivals, was in the habit of testing new drugs first on patients who had run out of other treatment options. If successful, it would try patients at an earlier stage of their disease, replacing older, established treatments. In today's market, where rivals in the United States and China catch up fast if a new class of drug shows promise, GSK has to run costly drug tests on humans in several settings at the same time, even if it means dropping other drug candidates. "Rather than do things sequentially, you do them in parallel, or as close to parallel as possible," Miels said. GSK, which is battling to return to profit growth, has taken this approach for instance with an experimental drug that for now goes by the code name of GSK'916 against multiple myeloma, a common and incurable type of blood cancer. Likewise, GSK doubled down on its quest to bring a drug known as GSK'165 to market as a rheumatoid arthritis treatment, even after initial results in a mid-stage drug trial did not show a clear enough reading. "This drug has very interesting effects on pain. That could potentially reduce the use of opioids and pain meds," Miels said. More trials will be run to make the pain argument more clearly, he added. GSK expects a decline of 5%-9% in adjusted earnings per share this year, excluding exchange rate moves, as it suffers from generic competition to its inhalable lung drug Advair and pressure from rival Gilead in HIV treatments. Miels said a tougher stance on drug prices by U.S. lawmakers and medical insurers was one of the reasons for the need for speed in bringing drugs to market - to try to remain ahead of competitors for as long as possible. At the same time, rapid growth in the Chinese market was spurring a more sophisticated healthcare system there, with local biotech groups quick to catch up with Western pioneers in drug development, producing similar drugs for their home market.

A: GSK pharma head flags need for speed in high-pressure drug market.
****
Q: "U.S. Sen. Kelly Ayotte, a Republican, is again backing programs aimed at identifying mentally ill people who pose a risk for mass killings. Ayotte, saying she has strong bipartisan support, has co-sponsored a bill geared toward education, awareness and intervention relating to mental illness since the mass shootings in Newtown, Conn., in December 2012. Ayotte introduced the Mental Health First Aid Act in January 2013, which never made it past a congressional committee. However, elements of that bill went into the Mental Health Awareness and Improvement Act that was part of the gun control legislation the Senate voted down in April. Two days after a mass shooting at the Washington Navy Yard in September 2013, Ayotte and Sen. Mark Begich, D-Alaska, issued a joint statement to Senate leadership advocating programs to educate teachers in recognizing symptoms of mental health illness and how they could defuse potentially dangerous situations. Soon after, she appeared on CNN's The Lead With Jake Tapper. She said a bill that addresses mental health issues would pass the Senate easily. Ayotte said the mental health amendment that was attached to last April's gun-control legislation passed easily. However, it was not enacted because the gun bill itself lost. ""I actually think it can be taken up separately and easily passed because of the mental health provisions. It got over 90 votes in the Senate and very little gets 90 votes around here,"" Ayotte said. We wondered whether the mental health amendment really got such overwhelming support. We looked at the official roll call vote on the amendment and found that it had indeed passed by a 95-2 vote on April 18. Despite voting for the mental health amendment she co-sponsored, Ayotte later became one of 41 Republicans who voted against the gun control proposal sponsored by Sens. Joe Manchin, D-W.Va., and Pat Toomey, R-Pa., that would have expanded background checks. Five Democrats also voted against it. The mixed messages these votes sent drew sharp criticism from critics. Ayotte responded with a statement that said: ""I believe that restricting the rights of law-abiding gun owners will not prevent a deranged individual or criminal from obtaining and misusing firearms to commit violence. While steps must be taken to improve the existing background check system, I will not support the Manchin-Toomey legislation, which I believe would place unnecessary burdens on law-abiding gun owners and allow for potential overreach by the federal government into private gun sales."" Our ruling Ayotte said that mental health provisions related to mass shootings ""got over 90 votes in the Senate."" While an early version of the bill never made it out of committee, the Senate did eventually vote, 95-2, for a mental-health amendment to a gun control bill. The full bill lacked enough votes to pass and was pulled from the floor, but she is correct that the amendment did get 90 votes."

A: "Mental health provisions related to mass shootings ""got over 90 votes in the Senate."
****
Q: "More than a month after Prince died at the age of 57, toxicology tests determined the visionary musician's cause of death: fentanyl, a synthetic opiate up to 50 times more potent than heroin. On June 6, 2016, Wisconsin Attorney General Brad Schimel penned a guest column in the Wisconsin State Journal connecting Prince's overdose to the state's opiate epidemic. He sought to end to the stigma around drug addiction and urged people to lock up prescription painkillers in their homes. Painkillers are often the starting point for people who develop opiate addictions. ""We must alter our view of opiates,"" Schimel wrote. ""More people now die in Wisconsin from drug overdoses than car crashes."" Is Schimel right that drug overdoses have not always outnumbered car accident fatalities in Wisconsin but do now? If accurate, it would strengthen his case that drug addiction has become an increasingly urgent issue. We decided to look at the numbers. Checking the figures In support of Schimel's statement, state Department of Justice spokesman Johnny Koremenos provided a report issued in September 2015 by the Wisconsin Department of Health Services. ""Deaths from drug poisoning, also called 'overdose,' have doubled since 2004 and surpassed motor vehicle traffic deaths in 2008,"" the report said. The sentence doesn't refer to the total number of deaths, but to age-adjusted death rates. That approach is used to better make comparisons across years, when the age structure of a population changes. An accompanying age-adjusted chart showed that 4 out of every 100,000 people died from a drug overdose in 1999 while 16 out of 100,000 did by 2013. The death rate from car crashes moderately declined during the same period, from around 13 out of 100,000 people to 9. Beginning in 2008, the death rate from drug overdoses surpassed the death rate from car crashes in the chart. We asked the Department of Health Services what the unadjusted numbers show. According to Jennifer Miller, spokeswoman for the Department of Health Services, 2009 was the first time that deaths from drug overdoses outnumbered deaths from car crashes in Wisconsin. And overdose deaths have outnumbered car crash deaths every year since. In 2014, the most recent year available, 843 people in Wisconsin died of drug overdoses while 558 died in car crashes. So both age-adjusted and raw numbers show that beginning in 2008 or 2009 (depending on which numbers you use) more people in Wisconsin died from drug use than from car crashes. Nationally, the total number of drug-related deaths surpassed the number of motor vehicle deaths in 2008 -- about the same time the numbers flipped in Wisconsin. Our rating Schimel said more people now die in Wisconsin from drug overdoses than car crashes. The most recent data available from 2014 supports his statement -- 2009 was the first year when more people died from drug overdoses than in car crashes."

A:
More people now die in Wisconsin from drug overdoses than car crashes.
****